“regulus-therapeutics” Archives

Entry Author Date Location
Regulus, UCSD Form Alliance 04/14/11 San Diego
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News 03/31/11 San Diego
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News 03/31/11 Seattle
Regulus Gets License From NYU 03/30/11 San Diego
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
John Mendlein Tries His Hand as a ‘Parallel Entrepreneur,’ Santaris Continues RNA Therapeutics Work for Pfizer, & More San Diego Life Sciences News 01/06/11 San Diego
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi 06/22/10 San Diego
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal with Glaxo 02/25/10 San Diego
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery 01/21/10 National
Ambit Signs Big Deal With Astellas, Xenomics Alleges Fraud at Sequenom, Arena Seeks FDA Approval for Weight-Loss Drug & More San Diego Life Sciences News 12/24/09 San Diego
Regulus Adds IP from Baltimore Lab 12/17/09 San Diego
Xconomy Forum: The Biotech Odyssey and Xconomy’s Ode to Innovation and Clean Air 12/15/09 San Diego
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday 12/09/09 San Diego
San Diego Biotech Leaders on the Future of Stem Cells, MicroRNA, & Cancer Biology 12/01/09 San Diego
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region 11/10/09 San Diego
Epizyme Grabs $32M, A123 Systems’ IPO Enriches BU, & More Boston-Area Deals News 10/12/09 Boston
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum 10/07/09 Boston
MicroRNA Drug Developer Santaris Establishes Toehold in San Diego With Isis Veteran 09/16/09 San Diego
$50M for Helicon, Cytori Bulks Up, Avanir Awaits Trial Results, & More San Diego Life Sciences News 07/30/09 San Diego
Alnylam and Isis’ Offspring, Regulus, Keeps Pushing on Biology’s ‘Bleeding Edge’ 07/28/09 San Diego
Regulus Hits GSK Milestone 05/14/09 San Diego
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers 04/29/09 San Diego
ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News 03/11/09 Boston
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News 03/06/09 Boston
Regulus Therapeutics Follows Through on Fundraising, Independence Plans 03/04/09 San Diego
Alnylam’s Spinoff Strategy, Genzyme’s Gaucher-Business Future, Adimab’s Antibody Ambitions, & More Boston-Area Life Sciences News 02/25/09 Boston
Alnylam Looks to Spinoffs To Unleash RNAi Technologies for Stem Cells, Vaccines 02/18/09 Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News 01/28/09 Boston
Page 2 of 3 « previous page · next page »